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Abstract The synthesis of 18F-perfluorinated motifs from [18F]fluoride is a non-
trivial undertaking as highlighted by the few methods and range of motifs 
that are known. In this Synpacts article we highlight our recent work on the 
synthesis and derivatization of 1,1-18F-difluoroalkenes to expand the 
accessible radiochemical space with fluorine-18.  
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1. Introduction 
Alkyl 18F-fluorides are arguably the most widely synthesized 
fluorinated motif with the radionuclide fluorine-18. This is in 
stark contrast to the abundance of alkyl 19F-fluorides in FDA 
approved active pharmaceutical ingredients, which stands at 14 
%, with the predominant motif being aryl fluorides.1 The 
discrepancy in the incidence of fluorinated motifs in the fields of 
radiochemistry and medicinal chemistry may simply be a result 
of the differing requirements of these molecules in their 
respective fields. However, we believe it more likely reflects the 
relative difficulty in introducing fluorine-18 into organic 
molecules, under radiochemical conditions, for the majority of 
fluorinated functional groups.  
It is well recognized that nucleophilic substitution of primary 
alkyl electrophiles with [18F]fluoride will normally yield the 
desired alkyl 18F-fluorides, and in sufficient quantities and high 
molar activities (Am), to allow for subsequent biological studies. 
Additionally, incorporation of a relatively small [18F]fluoroethyl 
group, for example, would be assumed to minimally perturb the 
biological properties of the compound of interest.2 However, in 
order for a radiolabeled molecule to be widely adopted for 
clinical use, its production should be compliant with the 
stringent requirements of current Good Manufacturing Practice 
(cGMP).3 The extra levels of complexity in many of the new 
synthetic methods to form 18F-(per)fluorinated motifs make 
cGMP compliance a non-trivial undertaking. As a consequence 
the tried and tested method of incorporating an 18F-alkyl 
fluoride is often preferred. While the majority of the recent 18F-
fluorination reactions for the synthesis of aryl fluorides, for 
example, have yet to be translated clinically, with continued 
development it is perhaps only a matter of time before this 
situation changes. 
The continued expansion in the variety of transformations with 
fluorine-18 available to radiochemists to include a wide range of 
perfluorinated motifs, will help to maintain the development 
and increase the potential of 18F-PET for molecular imaging 
applications.4 This Synpacts article highlights our recent work 
detailing the synthesis and derivatization of 1,1-18F-
difluorinated alkenes,5 in the context of current methods to 
synthesize 18F-perfluorinated compounds. 
2. Overview of the Main Strategies to Access 18F-
Perfluorinated Motifs with [18F]Fluoride 
The first reported methods to access 18F-perfluorinated 
functional groups examined the nucleophilic displacement of α,α-difluorinated electrophiles that were activated by the 
presence of an aromatic ring, or carbonyl group.6 While 
successful, these methods gave 18F-labelled products with molar 
activities much lower than that observed for non-fluorinated 
electrophiles. This decrease in Am was found to be due to the 
ability of the fluorinated precursors to act as sources of 
[19F]fluoride. These reactions have been re-visited by a number 
of research groups, describing milder reaction conditions and 
expanded substrate scopes, inclusive of sulfur and oxygen 
activated alkyl halides (Scheme 1a).7 An alternative route to 18F-
labelled aryl-CF3 compounds has been the development of 
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copper-mediated couplings between arylboronic acids or aryl 
iodides with [18F]CuCF3. The key difference between these new 
routes is the means of producing the key [18F]CuCF3 species 
(Scheme 1b).7 
 
Scheme 1 Main strategies to access 18F-perfluorinated motifs by nucleophilic 
substitution of perfluorinated electrophiles7 
While radiochemists can now readily access 18F-labelled aryl-
CF2H and aryl-CF3 substrates, albeit in low Am, general methods 
to access simple aliphatic systems are scarcer.8 The addition of 
[18F]fluoride to 1,1-difluorinated alkenes has been shown to be 
regioselective to give the corresponding aliphatic 18F-
trifluoromethyl compounds, although it appears to require 
systems whereby the intermediate anion is stabilized by the 
neighbouring functional group (Scheme 2a).9 Toste and co-
workers have reported arguably the only method that can 
produce aliphatic [18F]trifluoromethyl groups in positions that 
are neither structurally or electronically biased.10 Treatment of 
isolable Au(III) precursors with [18F]fluoride underwent 
reductive elimination to yield the desired aliphatic 18F-
trifluoromethylated compounds (Scheme 2b). To complement 
the synthesis of 18F-aryl-SCF3 compounds the related 18F-alkyl-
SCF3 substrates have also been reported. Key to this work was 
the synthesis of the [18F]SCF3 anion from difluorocarbene and 
sulfur, followed by subsequent reaction with an alkyl halide 
(Scheme 2c).11 This brief overview shows how major advances 
have been made recently in 18F-radiochemistry to increase the 
range of accessible labelled compounds for PET imaging. 
However, numerous perfluorinated functional groups, readily 
accessible to medicinal chemists, are not yet in reach for 
radiochemists. 
 
Scheme 2 General methods for the synthesis of alkyl-18F-CF3 motifs 
3. 1,1-18F-Difluoroalkenes 
One of the research themes within our group is to address the 
lack in diversity of 18F-perfluorinated motifs, and we were 
drawn to the synthesis of gem-18F-difluoroalkenes (Scheme 
3a).12 This functional group was attractive for two main reasons: 
firstly it is present in a range of pharmaceuticals,13 particular 
interesting was its presence in compounds to treat neurological 
disorders;14 secondly it displays a unique reactivity profile,15 
which we envisaged taking advantage of to gain access to 
additional 18F-perfluorinated motifs. 
The use of diaryliodonium salts for the synthesis 18F-aryl 
fluorides is a well-developed method,7 although to the best of 
our knowledge this methodology has never been adapted to the 
synthesis of 18F-alkenyl fluorides (Scheme 3b). 
 
Scheme 3 a) Prevalence of the 1,1-difluoroalkene functional group. b) 
Overview of our work on 1,1-18F-difluoroalkenes    
Based on the work of Ochiai et al on the reactivity 
alkenyl(aryl)iodonium salts with a variety of nucleophiles,16 we 
reasoned that 18F-fluorination of a fluoroalkenyl(aryl)iodonium 
salt should be regioselective to yield the desired 1,1-18F-
difluoroalkene. It is noteworthy that Ochiai had previously 
examined the nucleophilic substitution of 
alkenyl(phenyl)iodonium tetrafluoroborates with halides.17 
Iodide, bromide and chloride all gave the expected alkenyl 
halides, but the use of fluoride resulted in solely α-elimination 
and formation of the alkylidenecarbene (Scheme 4). 
 
Scheme 4 Nucleophilic substitution of (E)-β-alkyl(alkenyl)iodonium 
tetrafluoroborates with halides17 
While we were unconcerned by this pathway in our system due to the presence of the fluorine atom in the α-position, it does 
highlight a potential limitation in the use iodonium salts for the 
synthesis of fluoroalkenes. 
We began our studies by examining the fluorination of a range 
of fluoroalkenyl(aryl)iodonium triflates, where we varied the 
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identity of the aryl group.5 Of the groups tested 4-
methoxyphenyl was found to give the desired 1,1-18F-
difluoroalkene selectively with no formation of 4-
[18F]fluoroanisole. Addition of (2,2,6,6-tetramethylpiperodone-
1yl)oxidanyl (TEMPO) was found to significantly improve the 
reaction (Scheme 5a). With optimized conditions in hand 
([18F]KF/K222, TEMPO, CH3CN, 85 °C, 20 minutes), we proceeded 
to test the substrate scope and compatibility of the 
transformation. Pleasingly the reaction tolerated a wide variety 
of functional groups, inclusive of motifs present in medicinal 
compounds (Scheme 5b). In all cases the desired 1,1-18F-
difluoroalkene was formed selectively, and in good 
radiochemical purities (RCP), without any deviation from the 
optimized conditions. A range of heterocyclic compounds were 
also successfully fluorinated demonstrating the utility of this 
method for drug and radiotracer development (Scheme 5c). 
 
Scheme 5 Optimized conditions for synthesis of 1,1-18F-difluoroalkenes and 
substrate scope. RCP is reported for each compound as determined by radio-
HPLC and TLC. 
The ability to perform fluorine-18 radiochemical 
transformations on an automated synthesizer, in a shielded 
hotcell, is of critical importance. If this criterion is not met the 
protocol in question is likely to have limited applications due to 
safety considerations. Conscience of this requirement we tested 
our transformation on an automated synthesis unit (ELIXYS 
FLEC/CHEM coupled with ELIXYS PURE/FORM), gratifyingly we 
obtained radiochemical yields of 33-47 % (n = 3), with a Am of 1 GBqμmol-1. These results are suggestive that this methodology 
would be easily adopted by other radiochemical facilities for 
pre-clinical imaging. The origin of the isotopic dilution is not 
currently clear, although we believe decomposition of the 
starting material during the transformation and subsequent 
release of [19F]fluoride is likely responsible. The current Am of 
radiolabeled compound by this method is on par with that 
observed for 18F-perfluorinated systems, and efforts are 
currently underway to improve the Am of this transformation. 
With a practical method to readily produce the desired 1,1-18F-
difluoroalkenes we sought to investigate the use of these 
compounds to access other 18F-perfluorinated functional groups 
(Scheme 6). Using (1) as a model substrate we found that a thiyl 
radical and an alkoxide nucleophile both added regioselectively 
to give (2) and (3) respectively (Scheme 6a). The reduction of 
the 1,1-18F-difluorinated alkene was also possible within 5 
minutes at room temperature, to yield (4) in 49 ± 4 % (n = 3) 
RCP. Treatment of (1) with Selectfluor in water/CH3CN gave (5) 
in 61 ± 4 % (n = 3) RCP. The 1,3-dipolar cycloaddition of (1) 
with an in-situ generated azomethine, gave the 3,3-
[18F]difluoropyrrolidine (6) in 92 ± 3 % (n = 3) RCP. These 
results highlighting the potential of 1,1-18F-difluorinated 
alkenes as useful building blocks to access more complex 
radiolabeled molecules. 
 
Scheme 6 Diversification of 1,1-18F-difluoroalkenes to other 18F-motifs  
4. Conclusion 
A radiochemical synthesis of a range of 1,1-18F-difluoroalkenes 
has been reported from [18F]fluoride and 
fluoroalkenyl(aryl)iodonium triflates. The method is robust and 
readily adapted on to a commercially available automated 
synthesis unit. The gem-18F-difluoroalkene motif is of interest 
due to its presence in numerous pharmaceuticals, but also as a 
18F-building block. Five further 18F-perfluorinated motifs were 
ready accessed by post-labelling transformations that would be 
challenging to synthesize via currently available 18F-
radiochemical methods. Further work is underway on 
expanding the applications of this method. 
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